Influenza News and Research

Latest Influenza News and Research

Identifying the Starting Points for COVID19 Treatment

News-Medical spoke to researchers from the German Primate Center on their research in determining the activation sequence of the SARS-CoV-2 virus.

27 May 2020

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.

From EKF Diagnostics 26 May 2020

Preterm birth rates during COVID-19 in Denmark

The current COVID-19 outbreak was declared a pandemic in March 2020 by the World Health Organization (WHO). This led to the enforcement of a lockdown on an almost global scale with wide-ranging consequences. Now, a new Danish study published on the preprint server medRxiv* in May 2020 reveals the impact on preterm birth rates.

26 May 2020

SARS-CoV-2 is uniquely adapted to infect humans

The novel coronavirus pandemic has sparked much debate on its origin, with some suggesting it may have been laboratory-grown. Previous studies, however, mentioned that it is zoonotic in nature, which means that the virus jumped from wild animals and found its way to humans.

25 May 2020

Can Chlorpromazine help treat COVID-19?

A new research paper published in the journal L'Encéphale in May 2020 reports on the planned ReCoVery Study, which will examine the possibility of repurposing the antipsychotic drug chlorpromazine for the treatment of COVID-19.

25 May 2020

Capillary leakage important in COVID-19 respiratory distress

Now, a new study published on the preprint server medRxiv reports the pivotal role played by protein leakage through lung capillaries and promotes the use of serum albumin as a biomarker of disease progression and severity.

24 May 2020

Smokers at increased risk of severe COVID-19 according to a large population study

A new UK study available on the preprint server medRxiv screened 2.4 million users of a symptom reporting application during the coronavirus disease (COVID-19) pandemic, revealing that smokers are at higher risk of increased symptom burden and more prone to hospitalization.

24 May 2020

Portable analyzer rapidly detects anti-virus antibody in blood serum

Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.

22 May 2020

Revolutionary air disinfection system protects dentists against COVID-19

Eschmann Technologies has launched a revolutionary air disinfection system developed by Novaerus to help protect dentists against the spread of airborne viruses such as COVID-19.

22 May 2020

New review analyzes evidence and strategies to manage the SARS-CoV-2 virus

How should orthopaedic surgeons respond to the COVID-19 pandemic? A review in The Journal of Bone & Joint Surgery analyzes evidence and strategies for managing the novel SARS-CoV-2 virus - including critical lessons from past pandemics.

22 May 2020

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO specialized in the development and production of Advance Therapy Medicinal Products (ATMPs) and mammalian cell line-expressed biotherapeutics, today announced a collaboration to produce the novel human recombinant protein AT-100 (rhSP-D) as a therapeutic candidate against COVID-19.

21 May 2020

Excessive blood clotting and stroke in COVID-19 patients

The coronavirus disease COVID-19 is causing excessive blood clotting and stroke in young and healthy people, a new study has found.

21 May 2020

Main receptors used by SARS-CoV-2 for cell entry are absent in the human placenta

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unlikely to infect human placenta through the canonical cell entry mediators, Wayne State University researchers showed that other interacting proteins may still play an important role during the viral infection. The study is currently available on the preprint server bioRxiv.

20 May 2020

Certain corticosteroid could improve severe COVID-19, say researchers

Researchers at Wayne State University and Henry Ford Health System in Michigan have conducted a study indicating that the corticosteroid methylprednisolone could improve outcomes among patients with severe coronavirus disease 2019 (COVID-19).

20 May 2020

Scientists use machine learning methods to estimate COVID-19's seasonal cycle

One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu - waning in warm summer months then resurging in the fall and winter.

20 May 2020

Current antibody tests are good enough to inform decisions about public health, say experts

While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.

20 May 2020

Aerosol transmission through new vs. reused N95 masks

The world is grappling with the worst pandemic in over 100 years. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus which emerged in China in December 2019 but has now spread across the globe. With a rapid rate of transmission, SARS-CoV-2 has now affected over 4.88 million people and resulted in over 322,000 deaths.

19 May 2020

Influenza News and Research

Latest Influenza News and Research

Identifying the Starting Points for COVID19 Treatment

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

Preterm birth rates during COVID-19 in Denmark

SARS-CoV-2 is uniquely adapted to infect humans

Can Chlorpromazine help treat COVID-19?

Capillary leakage important in COVID-19 respiratory distress

Smokers at increased risk of severe COVID-19 according to a large population study

Portable analyzer rapidly detects anti-virus antibody in blood serum

Revolutionary air disinfection system protects dentists against COVID-19

New review analyzes evidence and strategies to manage the SARS-CoV-2 virus

Airway and Celonic collaborate to produce AT-100 as therapeutic candidate against COVID-19

Excessive blood clotting and stroke in COVID-19 patients

Main receptors used by SARS-CoV-2 for cell entry are absent in the human placenta

Certain corticosteroid could improve severe COVID-19, say researchers

Scientists use machine learning methods to estimate COVID-19's seasonal cycle

Current antibody tests are good enough to inform decisions about public health, say experts

Aerosol transmission through new vs. reused N95 masks

COVID-19 is more deadly than flu, concludes new study

Smoking increases ACE2 protein in the lungs which may promote COVID-19 infection

Local variations in climate not likely to drive early COVID-19 pandemic

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Influenza News and Research

Latest Influenza News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in